Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-25-002719·Denali Therapeutics Inc.
Schedule 13G ownership disclosure
Denali Therapeutics Inc
COMMON STOCK · CUSIP: 24823R105
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 8,536,392.34 · Class: 5.8%
- Abigail P. Johnson
Shares: 8,536,392.34 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-002719
- Form type
- SCHEDULE 13G/A
- Filer
- Denali Therapeutics Inc.
- CIK
- CIK 1714899
- Filed
- Nov 05, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership